Elevated levels of MMP-9 in the extracellular matrix are essential for the remodeling process of COPD patients and their expression is regulated by specific inhibitors, such as tissue inhibitor of metalloproteinases-1 (TIMP-1). Here, MMP9 is linked to chronic obstructive pulmonary disease.